Interim report
Page 1
MYCRONIC Interim Report January - March 2021 First quarter Q1 ■ Order intake amounted to SEK 1,027 ( 1,432 ) million , a decline of 28 percent " ■ Net sales increased 75 percent to SEK 1,291 ( 736 ) million . Based on constant exchange rates the increase was 88 percent EBIT increased to SEK 498 ( 55 ) million and EBIT margin was 39 ( 8 ) percent ▪ Earnings per share were SEK 3.99 ( 0.40 ) " We delivered a stable start to the year . We continue to focus on helping our customers address the challenges still being created by the pandemic . We delivered growth of 75 percent and the EBIT margin improved to 39 percent , which was largely explained by good growth in the High Volume division and a strong quarter for the Pattern Generator division attributed to the delivery of a Prexision 800 Evo . The order decline of 28 percent should be viewed in relation to a challenging comparison with the first quarter of 2020 when order intake included five mask writers . This is a result that I am very satisfied with , at the same time as I can see potential for further improvements , particularly in the High Flex and Global Technologies divisions , " says Anders Lindqvist , President and CEO . Outlook 2021 It is the Board of Directors ' opinion that consolidated net sales for 2021 will be at a level of SEK 3.9 billion , based on 2020 closing exchange rates . Q1 Rolling Jan - Dec Group summary Order intake , SEK million Net Sales , SEK million Book - to - bill 2021 2020 12 month 2020 1,027 1,432 3,282 3,687 1,291 736 4,437 3,882 0.8 1.9 0.7 0.9 Order backlog , SEK million 1,706 2,860 1,706 1,969 Gross margin , % 59.8 % 45.4 % 56.7 % 53.6 % EBIT , SEK million 498 55 1,340 898 EBIT margin , % 38.6 % 7.5 % 30.2 % 23.1 % Earnings per share before / after dilution , SEK 3.99 0.40 10.69 7.10 Cash Flow , SEK million 311 228 772 689 Changes in Net Sales Total growth , % Organic growth , % Growth from acquisitions , % Currency effects , % 75 % -33 % 13 % -10 % 88 % -35 % 18 % -8 % -12 % 2 % -5 % -2 % 1 ( 19 ) Interim Report January - March 2021